Skip to main content
Fig. 1 | Health and Quality of Life Outcomes

Fig. 1

From: Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients

Fig. 1

Studies reporting adverse event health state (dis) utilities by patient population and country. Abbreviations: 1L first line, 2L second line, BC breast cancer, BM bone metastasis, Hb haemoglobin, i.v. intravenous, LC lung cancer, LNS line of treatment not specified, mLC metastatic lung cancer, mNSCLC metastatic non-small cell lung cancer, NICE National Institute for Health and Care Excellence, NSCLC non-small cell lung cancer, SCLC small cell lung cancer, SRE skeletal-related event

Back to article page